首页> 外国专利> COMPOSITION FOR PREVENTING OR TREATING INFECTIOUS DISEASES CAUSED BY MYCOBACTERIUM TUBERCULOSIS, NONTUBERCULOUS MYCOBACTERIA OR GRAM-POSITIVE BACTERIA, CONTAINING MMAGNU2 COMPOUND AS ACTIVE INGREDIENT

COMPOSITION FOR PREVENTING OR TREATING INFECTIOUS DISEASES CAUSED BY MYCOBACTERIUM TUBERCULOSIS, NONTUBERCULOUS MYCOBACTERIA OR GRAM-POSITIVE BACTERIA, CONTAINING MMAGNU2 COMPOUND AS ACTIVE INGREDIENT

机译:用于预防或治疗由结核分枝杆菌,无萎缩的分枝杆菌或革兰氏阳性细菌引起的传染病的组合物,含有Mmagnu2化合物作为活性成分

摘要

The present invention relates to a composition for preventing, alleviating or treating infectious diseases caused by Mycobacterium tuberculosis, nontuberculous mycobacteria (NTM) or gram-positive bacteria, containing MMAGNU2 compound as an active ingredient. Specifically, it has been ascertained that Mycobacterium tuberculosis, Mycobacterium tuberculosis H37Rv, and a non-proliferative M. tuberculosis SS18b strain are effectively inhibited in vitro and nontuberculous mycobacteria, Mycobacterium abscessus is effectively inhibited in vitro and in zebrafish in vivo, and thus the present invention can be used in a pharmaceutical composition and a health functional food that is useful in the prevention, alleviation and treatment of infectious diseases caused by Mycobacterium tuberculosis and nontuberculous mycobacteria. In addition, Staphylococcus aureus, Micrococcus luteus and Enterococcus faecalis, which are gram-positive bacteria, are effectively inhibited in ex vivo experiments, and thus the present invention can be used as effective treatment for gram-positive bacterial infection.
机译:本发明涉及用于预防,减轻或治疗由含有Mmagnu2化合物作为活性成分的Mmagnu2化合物引起的感染性疾病的组合物,减轻或治疗引起的传染性疾病。具体而言,已经确定了结核分枝杆菌,结核分枝杆菌 - H37RV,以及非增殖性 m。肺结核 SS18B菌株在体外抑制体外和不泛骨的分枝杆菌,在体内和斑马鱼中有效地抑制了分枝杆菌和斑马鱼,因此本发明可用于药物组合物和a健康功能性食品可用于预防,缓解和治疗由结核分枝杆菌和非泛菌的分枝杆菌引起的传染病。另外,在离体实验中有效地抑制了微球菌,微球菌,微观菌,微观菌,其中克阳性细菌的肠球菌粪便,因此本发明可用作革兰氏阳性细菌感染的有效处理。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号